{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:35:51Z","timestamp":1791570951496,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYGD20008"],"award-info":[{"award-number":["ZYGD20008"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYJC18030"],"award-info":[{"award-number":["ZYJC18030"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYJC18007"],"award-info":[{"award-number":["ZYJC18007"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772693"],"award-info":[{"award-number":["81772693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002648"],"award-info":[{"award-number":["82002648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Major Scientific and Technological Special Project for Significant New Drug Development","award":["2019ZX09301-147"],"award-info":[{"award-number":["2019ZX09301-147"]}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2019YFS0392"],"award-info":[{"award-number":["2019YFS0392"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2019YFS0326"],"award-info":[{"award-number":["2019YFS0326"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2018M640922"],"award-info":[{"award-number":["2018M640922"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the critical structure in the central brain. CP can be divided into two major histologic subtypes: adamantinomatous-type CP (ACP) and papillary-type CP (PCP). Although some genetic aberrations for both categories have been revealed in previous studies, the complete spectrum of genetic changes of this tumor remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we conducted whole genome sequencing (WGS) on twenty-six CPs including 16 ACPs and 10 PCPs together with their matched blood samples. Somatic variants (SNVs, InDels, SVs and CNVs) were identified and mutational signatures were characterized for each patient. We investigated the impact of a novel CTNNB1 mutant on its protein stability, ubiquitination and Wnt pathway activity. Cell proliferation ability of the CTNNB1 mutant in ACP primary cells was additionally analyzed by CCK8 and colony formation assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that CPs had showed less complexity with fewer somatic mutations compared with malignant tumors. Moreover, mutations in CTNNB1 (68.75% of ACP) and BRAF V600E (70.00% of PCP) are mutually exclusive in ACP and PCP, consolidating that the driving roles of these two genes in ACP and PCP, respectively. A novel mutation in the exon 3 of CTNNB1 which compromised both a transversion and in-frame deletion was identified in ACP. This mutation was experimentally validated to confer \u03b2-catenin increased stability by inhibiting its ubiquitination, thus activating Wnt-signaling pathway and promoting cell proliferation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Whole genome landscape for CP was revealed by WGS analysis, and a novel mutation in the exon 3 of CTNNB1 was identified. This novel mutation activates Wnt-signaling pathway through increasing the stability of \u03b2-catenin. Our findings provided us with more comprehensive insight into the spectrum of genetic alterations in CP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12943-021-01468-7","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T07:02:44Z","timestamp":1639810964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing"],"prefix":"10.1186","volume":"20","author":[{"given":"Juan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangxue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1181-3467","authenticated-orcid":false,"given":"Yong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"issue":"1","key":"1468_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"HL M\u00fcller","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Rev Dis Primers. 2019;5(1):75.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"1468_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11102-021-01127-6","volume":"24","author":"AA Momin","year":"2021","unstructured":"Momin AA, Recinos MA, Cioffi G, Patil N, Soni P, Almeida JP, et al. Descriptive epidemiology of craniopharyngiomas in the United States. Pituitary. 2021;24(4):517\u201322.","journal-title":"Pituitary."},{"issue":"5","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrendo.2016.217","volume":"13","author":"HL Muller","year":"2017","unstructured":"Muller HL, Merchant TE, Puget S, Martinez-Barbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol. 2017;13(5):299\u2013312.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1468_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11060-012-0806-7","volume":"108","author":"A Schoenfeld","year":"2012","unstructured":"Schoenfeld A, Pekmezci M, Barnes MJ, Tihan T, Gupta N, Lamborn KR, et al. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neuro-Oncol. 2012;108(1):133\u20139.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"1468_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-012-0402-z","volume":"16","author":"G Barkhoudarian","year":"2013","unstructured":"Barkhoudarian G, Laws ER. Craniopharyngioma: history. Pituitary. 2013;16(1):1\u20138.","journal-title":"Pituitary"},{"issue":"1\u20132","key":"1468_CR6","first-page":"7","volume":"28","author":"JP Martinez-Barbera","year":"2015","unstructured":"Martinez-Barbera JP, Buslei R. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models. J Pediatr Endocrinol Metab. 2015;28(1\u20132):7\u201317.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"1468_CR7","doi-asserted-by":"publisher","first-page":"e000406","DOI":"10.1136\/jitc-2019-000406","volume":"8","author":"Y Wang","year":"2020","unstructured":"Wang Y, Deng J, Wang L, Zhou T, Yang J, Tian Z, et al. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma. J Immunother Cancer. 2020;8(2):e000406.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"1468_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00401-005-1004-x","volume":"109","author":"R Buslei","year":"2005","unstructured":"Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, et al. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol. 2005;109(6):589\u201397.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1468_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12672-010-0041-7","volume":"1","author":"ML Campanini","year":"2010","unstructured":"Campanini ML, Colli LM, Paixao BM, Cabral TP, Amaral FC, Machado HR, et al. CTNNB1 gene mutations, pituitary transcription factors, and microRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas. Horm Cancer. 2010;1(4):187\u201396.","journal-title":"Horm Cancer"},{"issue":"2","key":"1468_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.2868","volume":"46","author":"PK Brastianos","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46(2):161\u20135.","journal-title":"Nat Genet"},{"issue":"6","key":"1468_CR11","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64477-X","volume":"161","author":"S Sekine","year":"2002","unstructured":"Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, et al. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161(6):1997\u20132001.","journal-title":"Am J Pathol"},{"issue":"3","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/path.1562","volume":"203","author":"K Kato","year":"2004","unstructured":"Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203(3):814\u201321.","journal-title":"J Pathol"},{"issue":"2","key":"1468_CR13","first-page":"126","volume":"76","author":"T Goschzik","year":"2017","unstructured":"Goschzik T, Gessi M, Dreschmann V, Gebhardt U, Wang L, Yamaguchi S, et al. Genomic alterations of adamantinomatous and papillary craniopharyngioma. J Neuropathol Exp Neurol. 2017;76(2):126\u201334.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"14","key":"1468_CR14","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics."},{"issue":"9","key":"1468_CR15","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"3","key":"1468_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213\u20139.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"1468_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim S, Scheffler K, Halpern AL, Bekritsky MA, Noh E, Kallberg M, et al. Fast and accurate calling of germline and somatic variants. Nat Methods. 2018;15(8):591\u20134.","journal-title":"Nat Methods"},{"issue":"3","key":"1468_CR18","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568\u201376.","journal-title":"Genome Res"},{"issue":"7","key":"1468_CR19","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2019.05.013","volume":"177","author":"JJ Lee","year":"2019","unstructured":"Lee JJ, Park S, Park H, Kim S, Lee J, Lee J, et al. Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma. Cell. 2019;177(7):1842\u201357.","journal-title":"Cell."},{"issue":"1","key":"1468_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero F, Joshi T, Marquard AM, Birkbak NJ, Krzystanek M, Li Q, et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann Oncol. 2015;26(1):64\u201370.","journal-title":"Ann Oncol"},{"key":"1468_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal R, McGranahan N, Herrero J, Taylor BS, Swanton C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 2016;17:31.","journal-title":"Genome Biol"},{"issue":"1","key":"1468_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34.","journal-title":"Genome Med"},{"issue":"1","key":"1468_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12894-021-00795-7","volume":"21","author":"L Wang","year":"2021","unstructured":"Wang L, Pan S, Zhu B, Yu Z, Wang W. Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer. BMC Urol. 2021;21(1):29.","journal-title":"BMC Urol"},{"issue":"7267","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071\u20138.","journal-title":"Nature."},{"issue":"7457","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214\u20138.","journal-title":"Nature."},{"issue":"12","key":"1468_CR26","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/nsmb.1725","volume":"16","author":"AJ Cesare","year":"2009","unstructured":"Cesare AJ, Kaul Z, Cohen SB, Napier CE, Pickett HA, Neumann AA, et al. Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat Struct Mol Biol. 2009;16(12):1244\u201351.","journal-title":"Nat Struct Mol Biol"},{"issue":"5-6","key":"1468_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00439-009-0657-2","volume":"125","author":"GP Pfeifer","year":"2009","unstructured":"Pfeifer GP, Besaratinia A. Mutational spectra of human cancer. Hum Genet. 2009;125(5-6):493\u2013506.","journal-title":"Hum Genet"},{"issue":"7605","key":"1468_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534(7605):47\u201354.","journal-title":"Nature."},{"issue":"9","key":"1468_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/gm490","volume":"5","author":"RS Harris","year":"2013","unstructured":"Harris RS. Cancer mutation signatures, DNA damage mechanisms, and potential clinical implications. Genome Med. 2013;5(9):87.","journal-title":"Genome Med."},{"issue":"7463","key":"1468_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415\u201321.","journal-title":"Nature."},{"issue":"5","key":"1468_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-010-0642-9","volume":"119","author":"A Holsken","year":"2010","unstructured":"Holsken A, Buchfelder M, Fahlbusch R, Blumcke I, Buslei R. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol. 2010;119(5):631\u20139.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1468_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/MCB.06409-11","volume":"32","author":"M Nishiyama","year":"2012","unstructured":"Nishiyama M, Skoultchi AI, Nakayama KI. Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-beta-catenin signaling pathway. Mol Cell Biol. 2012;32(2):501\u201312.","journal-title":"Mol Cell Biol"},{"issue":"36","key":"1468_CR33","doi-asserted-by":"publisher","first-page":"22390","DOI":"10.1073\/pnas.2008724117","volume":"117","author":"S Shi","year":"2020","unstructured":"Shi S, Yang ZZ, Liu S, Yang F, Lin H. PIWIL1 promotes gastric cancer via a piRNA-independent mechanism. Proc Natl Acad Sci U S A. 2020;117(36):22390\u2013401.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1468_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s13577-020-00463-2","volume":"34","author":"J Xie","year":"2021","unstructured":"Xie J, Xing S, Shen BY, Chen HT, Sun B, Wang ZT, et al. PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5. Hum Cell. 2021;34(2):550\u201363.","journal-title":"Hum Cell"},{"issue":"7","key":"1468_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","volume":"20","author":"T Kurosaki","year":"2019","unstructured":"Kurosaki T, Popp MW, Maquat LE. Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat Rev Mol Cell Biol. 2019;20(7):406\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1468_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc2290","volume":"8","author":"M Welcker","year":"2008","unstructured":"Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 2008;8(2):83\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1468_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/pcmr.12603","volume":"30","author":"IT Aydin","year":"2017","unstructured":"Aydin IT, Abbate F, Rajan GS, Badal B, Aifantis I, Desman G, et al. FBXW7 inactivation in a Braf(V600E) -driven mouse model leads to melanoma development. Pigment Cell Melanoma Res. 2017;30(6):571\u20134.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"38","key":"1468_CR38","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/onc.2014.69","volume":"33","author":"JM Bugter","year":"2014","unstructured":"Bugter JM, Fenderico N, Maurice MM. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat rev Cancer. 2021;21(1):5-21.39. Lee IH, Sohn M, Lim HJ, Yoon S, Oh H, shin S, et al. AHNAK functions as a tumor suppressor via modulation of TGFbeta\/Smad signaling pathway. Oncogene. 2014;33(38):4675\u201384.","journal-title":"Oncogene."},{"issue":"5","key":"1468_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00401-018-1830-2","volume":"135","author":"JR Apps","year":"2018","unstructured":"Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, et al. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target. Acta Neuropathol. 2018;135(5):757\u201377.","journal-title":"Acta Neuropathol"},{"issue":"31","key":"1468_CR40","doi-asserted-by":"publisher","first-page":"49998","DOI":"10.18632\/oncotarget.10307","volume":"7","author":"TA Silva","year":"2016","unstructured":"Silva TA, Smuczek B, Valadao IC, Dzik LM, Iglesia RP, Cruz MC, et al. AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility. Oncotarget. 2016;7(31):49998\u201350016.","journal-title":"Oncotarget."},{"issue":"2","key":"1468_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/CMR.0000000000000228","volume":"26","author":"HM Sheppard","year":"2016","unstructured":"Sheppard HM, Feisst V, Chen J, Print C, Dunbar PR. AHNAK is downregulated in melanoma, predicts poor outcome, and may be required for the expression of functional cadherin-1. Melanoma Res. 2016;26(2):108\u201316.","journal-title":"Melanoma Res"},{"issue":"1","key":"1468_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-017-0522-4","volume":"36","author":"B Chen","year":"2017","unstructured":"Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian Z, et al. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. J Exp Clin Cancer Res. 2017;36(1):65.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1468_CR43","doi-asserted-by":"publisher","first-page":"e56420","DOI":"10.1371\/journal.pone.0056420","volume":"8","author":"CA Dumitru","year":"2013","unstructured":"Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S. AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma. PLoS One. 2013;8(2):e56420.","journal-title":"PLoS One"},{"issue":"1","key":"1468_CR44","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1038\/s41467-021-24639-y","volume":"12","author":"N Singh","year":"2021","unstructured":"Singh N, Reyes-Ordo\u00f1ez A, Compagnone MA, Moreno JF, Leslie BJ, Ha T, et al. Redefining the specificity of phosphoinositide-binding by human PH domain-containing proteins. Nat Commun. 2021;12(1):4339.","journal-title":"Nat Commun"},{"issue":"9","key":"1468_CR45","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/stem.2660","volume":"35","author":"T Vanova","year":"2017","unstructured":"Vanova T, Konecna Z, Zbonakova Z, Venuta GL, Zoufalova K, Jelinkova S, et al. Tyrosine kinase expressed in hepatocellular carcinoma, TEC, controls pluripotency and early cell fate decisions of human pluripotent stem cells via regulation of fibroblast growth factor-2 secretion. Stem Cells. 2017;35(9):2050\u20139.","journal-title":"Stem Cells"},{"issue":"42","key":"1468_CR46","doi-asserted-by":"publisher","first-page":"14134","DOI":"10.1523\/JNEUROSCI.1711-10.2010","volume":"30","author":"D Oh","year":"2010","unstructured":"Oh D, Han S, Seo J, Lee JR, Choi J, Groffen J, et al. Regulation of synaptic Rac1 activity, long-term potentiation maintenance, and learning and memory by BCR and ABR Rac GTPase-activating proteins. J Neurosci. 2010;30(42):14134\u201344.","journal-title":"J Neurosci"},{"issue":"17","key":"1468_CR47","first-page":"5234","volume":"63","author":"ZH Wang","year":"2003","unstructured":"Wang ZH, Vogelstein B, Kinzler KW. Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells. Cancer Res. 2003;63(17):5234\u20135.","journal-title":"Cancer Res"},{"issue":"5382","key":"1468_CR48","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509\u201312.","journal-title":"Science."},{"issue":"9","key":"1468_CR49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","volume":"21","author":"C Lourenco","year":"2021","unstructured":"Lourenco C, Resetca D, Redel C, Lin P, MacDonald AS, Ciaccio R, et al. MYC protein interactors in gene transcription and cancer. Nat Rev Cancer. 2021;21(9):579\u201391.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1468_CR50","doi-asserted-by":"publisher","first-page":"188517","DOI":"10.1016\/j.bbcan.2021.188517","volume":"1875","author":"M Panda","year":"2021","unstructured":"Panda M, Tripathi SK, Biswal BK. SOX9: an emerging driving factor from cancer progression to drug resistance. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188517.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"12","key":"1468_CR51","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41419-020-03273-4","volume":"11","author":"TC Zhou","year":"2020","unstructured":"Zhou TC, Wu LL, Ma N, Tang FX, Yu ZM, Jiang ZP, et al. SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9. Cell Death Dis. 2020;11(12):1071.","journal-title":"Cell Death Dis"},{"issue":"42","key":"1468_CR52","doi-asserted-by":"publisher","first-page":"17053","DOI":"10.1073\/pnas.1313650110","volume":"110","author":"M Ono","year":"2013","unstructured":"Ono M, Yin P, Navarro A, Moravek MB, JSt C, Druschitz SA, et al. Paracrine activation of WNT\/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U S A. 2013;110(42):17053\u20138.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-021-01468-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T05:08:14Z","timestamp":1676092094000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-021-01468-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,18]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1186\/s12943-021-01468-7","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,18]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Biomedical Ethics Committee of West China Hospital of Sichuan University. All patients provided written informed consent for genomic analysis of their cancer as well as participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors approved the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}